Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-022728
Filing Date
2024-06-05
Accepted
2024-06-05 16:05:51
Documents
55
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 947230
2 ex31-1.htm EX-31.1 18197
3 ex31-2.htm EX-31.2 18236
4 ex32-1.htm EX-32.1 8082
5 ex32-2.htm EX-32.2 8166
  Complete submission text file 0001493152-24-022728.txt   5155716

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pwup-20240331.xsd EX-101.SCH 44311
7 XBRL CALCULATION FILE pwup-20240331_cal.xml EX-101.CAL 30351
8 XBRL DEFINITION FILE pwup-20240331_def.xml EX-101.DEF 245491
9 XBRL LABEL FILE pwup-20240331_lab.xml EX-101.LAB 296950
10 XBRL PRESENTATION FILE pwup-20240331_pre.xml EX-101.PRE 268152
59 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 752437
Mailing Address 1200 BROADWAY, FLOOR 3 NEW YORK NY 10038
Business Address 1200 BROADWAY, FLOOR 3 NEW YORK NY 10038 561-704-8527
PowerUp Acquisition Corp. (Filer) CIK: 0001847345 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41293 | Film No.: 241022008
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)